A

AFC-HD AMS Life Science Co Ltd
TSE:2927

Watchlist Manager
AFC-HD AMS Life Science Co Ltd
TSE:2927
Watchlist
Price: 907 JPY 1.34% Market Closed
Market Cap: ¥12.8B

Wall Street
Price Targets

Price Targets Summary
AFC-HD AMS Life Science Co Ltd

There are no price targets for AFC-HD AMS Life Science Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
AFC-HD AMS Life Science Co Ltd Competitors:
Price Targets
WICE
WICE Logistics PCL
-2% Downside
AOF
Atoss Software AG
60% Upside

Revenue
Forecast

6% / Year
Past Growth
-14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
-14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's revenue is 6%. The projected CAGR for the next 5 years is -14%.

Operating Income
Forecast

10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
AFC-HD AMS Life Science Co Ltd

Net Income
Forecast

7% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
7% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's net income is 7%. The projected CAGR for the next 5 years is -15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFC-HD AMS Life Science Co Ltd's stock price target?
Not Available

AFC-HD AMS Life Science Co Ltd doesn't have any price targets made by Wall Street professionals.

What is AFC-HD AMS Life Science Co Ltd's Revenue forecast?
Projected CAGR
-14%

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's revenue is 6%. The projected CAGR for the next 5 years is -14%.

What is AFC-HD AMS Life Science Co Ltd's Net Income forecast?
Projected CAGR
-15%

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's net income is 7%. The projected CAGR for the next 5 years is -15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett